Role of dopamine transporter (DAT) in dopamine transport across the nasal mucosa

Life Sciences

Volumn 79, Issue 14, 2006, Pages 1391-1398

  Chemuturi, Nagendra V ^a   Haraldsson, Jon E ^b   Prisinzano, Thomas ^a   Donovan, Maureen ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Dopamine transporter; Nasal absorption; Olfactory transport

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COW; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NOSE MUCOSA; OLFACTORY EPITHELIUM; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOTTING, WESTERN; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTRIC CONDUCTIVITY; FLUORESCENT DYES; IMMUNOHISTOCHEMISTRY; ISOQUINOLINES; NASAL MUCOSA; PIPERAZINES;

BOS TAURUS;

EID: 33747054456     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.04.021     Document Type: Article

References (39)

1. Anand Kumar T.C., David G.F.X., Kumar K., Umberkoman B., and Krishnamoorthy M.S. A new approach to fertility regulation by interfering with neuroendocrine pathways. Neuroendocrine Regulation of Fertility (1974) 314-322
2. Appell M., Berfield J.L., Wang L.C., Dunn W.J., Chen N., and Reith M.E. Structure-activity relationships for substrate recognition by the human dopamine transporter. Biochemical Pharmacology 67 (2004) 293-302
3. Breidert T., Spitzenberger F., Grundemann D., and Schomig E. Catecholamine transport by the organic cation transporter type 1 (OCT1). British Journal of Pharmacology 125 (1998) 218-224
4. Bruss M., Wieland A., and Bonisch H. Molecular cloning and functional expression of the mouse dopamine transporter. Journal of Neural Transmission 106 (1999) 657-662
5. Carr V.M., Walters E., Margolis F.L., and Farbman A.I. An enhanced olfactory marker protein immunoreactivity in individual olfactory receptor neurons following olfactory bulbectomy may be related to increased neurogenesis. Journal of Neurobiology 34 (1998) 377-390
6. Chemuturi N.V. The Characterization of Bio-molecular Processes Controlling Dopamine Transport Across the Nasal Mucosa (2005), Division of Pharmaceutics, The University of Iowa, Iowa City
7. Chen N., and Reith M.E. Structure and function of the dopamine transporter. European Journal of Pharmacology 405 (2000) 329-339
8. + and the substrate permeation pathway in dopamine transporters. European Journal of Pharmacology 479 (2003) 213-221
9. + with the binding of the cocaine analogue 3beta-(4-[125I]iodophenyl)tropane-2beta-carboxylic acid isopropyl ester to the dopamine transporter. Journal of Neurochemistry 68 (1997) 1968-1981
10. Chen N., Ferrer J.V., Javitch J.A., and Justice Jr. J.B. Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter. Journal of Biological Chemistry 275 (2000) 1608-1614
11. Chen N., Sun L., and Reith M.E. Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 alpha-carbomethoxy-3 alpha-(4-fluorophenyl)tropane. Journal of Neurochemistry 81 (2002) 1383-1393
12. + stimulates binding of dopamine to the dopamine transporter in cells but not in cell-free preparations. Journal of Neurochemistry 86 (2003) 678-686
13. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., and Levey A.I. The dopamine transporter: immunochemical characterization and localization in brain. Journal of Neuroscience 15 (1995) 1714-1723
14. Dahlin M., Bergman U., Jansson B., Bjork E., and Brittebo E. Transfer of dopamine in the olfactory pathway following nasal administration in mice. Pharmaceutical Research 17 (2000) 737-742
15. Dahlin M., Jansson B., and Bjork E. Levels of dopamine in blood and brain following nasal administration to rats. European Journal of Pharmaceutical Sciences 14 (2001) 75-80
16. Hersch S.M., Yi H., Heilman C.J., Edwards R.H., and Levey A.I. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. The Journal of Comparative Neurology 388 (1997) 211-227
17. Hoffman R.P., Sinkey C.A., Dopp J.M., and Phillips B.G. Systemic and local adrenergic regulation of muscle glucose during hypoglycemia in healthy subjects. Diabetes 51 (2002) 734-742
18. Ironside M.D., Sugathapala P.M., Robertson J., Darey M.C.P., and Zhang J. Scale-up synthesis of the dopamine uptake inhibitor GBR-12909. Organic Process Research and Development 6 (2002) 621-627
19. Kandimalla K.K., and Donovan M.D. Carrier mediated transport of chlorpheniramine and chlorcyclizine across bovine olfactory mucosa: implications on nose-to-brain transport. Journal of Pharmaceutical Sciences 94 (2005) 613-624
20. Kandimalla K.K., and Donovan M.D. Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae. Pharmaceutical Research 22 (2005) 1121-1128
21. Kandimalla K.K., and Donovan M.D. Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: role of passive diffusion in the direct nose-to-brain uptake of small molecules. International Journal of Pharmaceutics 302 (2005) 133-144
22. Lee F.J., Pristupa Z.B., Ciliax B.J., Levey A.I., and Niznik H.B. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain. Journal of Biological Chemistry 271 (1996) 20885-20894
23. + uptake and cocaine binding in bovine dopamine transporter. Neuroscience Letters 214 (1996) 199-201
24. Lee S.H., Kang S.S., Son H., and Lee Y.S. The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function. Biochemical and Biophysical Research Communications 246 (1998) 347-352
25. Lee S.H., Chang M.Y., Jeon D.J., Oh D.Y., Son H., Lee C.H., and Lee Y.S. The functional domains of dopamine transporter for cocaine analog, CFT binding. Experimental and Molecular Medicine 34 (2002) 90-94
26. Li L.B., Chen N., Ramamoorthy S., Chi L., Cui X.N., Wang L.C., and Reith M.E. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. Journal of Biological Chemistry 279 (2004) 21012-21020
27. Menco B.P. Qualitative and quantitative freeze-fracture studies on olfactory and nasal respiratory epithelial surfaces of frog, ox, rat, and dog. II. Cell apices, cilia, and microvilli. Cell and Tissue Research 211 (1980) 5-29
28. Mezey E., Eisenhofer G., Harta G., Hansson S., Gould L., Hunyady B., and Hoffman B.J. A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 10377-10382
29. Mezey E., Eisenhofer G., Hansson S., Harta G., Hoffman B.J., Gallatz K., Palkovits M., and Hunyady B. Non-neuronal dopamine in the gastrointestinal system. Clinical and Experimental Pharmacology and Physiology. Supplement 26 (1999) S14-S22
30. Monte J.C., Nagle M.A., Eraly S.A., and Nigam S.K. Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochemical and Biophysical Research Communications 323 2 (2004) 429-436
31. Piccini P.P. Dopamine transporter: basic aspects and neuroimaging. Movement Disorders. Supplement 18 7 (2003) S3-S8
32. Revay R., Vaughan R., Grant S., and Kuhar M.J. Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain. Synapse 22 2 (1996) 93-99
33. Schmidt M.C., Simmen D., Hilbe M., Boderke P., Ditzinger G., Sandow J., Lang S., Rubas W., and Merkle H.P. Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epithelium. Journal of Pharmaceutical Sciences 89 3 (2000) 396-407
34. 3H]dopamine uptake. Neurochemistry International 15 (1989) 325-332
35. Sorkina T., Hoover B.R., Zahniser N.R., and Sorkin A. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6 (2005) 157-170
36. Surratt C., Johnson P., Moriwaki A., Seidleck B., Blaschak C., Wang J., and Uhl G. μ Opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. Journal of Biological Chemistry 269 (1994) 20548-20553
37. Syringas M., Janin F., Giros B., Costentin J., and Bonnet J.J. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake. British Journal of Pharmacology 133 (2001) 387-394
38. Usdin T.B., Mezey E., Chen C., Brownstein M.J., and Hoffman B.J. Cloning of the cocaine-sensitive bovine dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America 88 (1991) 11168-11171
39. Watanabe Y., Himeda T., and Araki T. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease. Medical Science Monitor 11 (2005) RA17-RA23